Investigational Site Number :0360001

Fitzroy, Victoria 3065

0 studies enrolling now · 2 studies all time

What they study most

Non-relapsing Secondary Progressive Multiple Sclerosis, Plasma Cell Myeloma

Studies at this site

• Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients — Completed
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed